Price $49.80 |
Market Cap
104.04B
|
Sector Health Care |
Div. Growth
6.60%
|
|
P/E
13.4
|
P/B
3.75
|
P/S
2.42
|
Dividend %
4.30%
|
|
P/CF
-
|
P/FCF
15.9
|
Op. Cash Flow
12.91M
|
FCF
3.3
|
|
Op. Margin
21.80%
|
Net Margin
18.40%
|
ROE
26.80%
|
ROI
11.80%
|
|
ROA
8.80%
|
EPS Growth
28.20%
|
Current Ratio
1.2
|
Debt/Equity
112.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
| Journey Medical Corp (DERM) | $4.70 | - | - | 43.3M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $108.39 | - | - | 8.13B | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $3.16 | - | - | 2.3M | Strong Buy |
| Inotiv Inc (NOTV) | $1.44 | - | - | 46.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
